Amanote Research
Register
Sign In
Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence
Current Oncology
- Canada
doi 10.3747/co.v17i4.560
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
July 22, 2010
Authors
J. Younus
S. Verma
J. Franek
N. Coakley
Publisher
MultiMed Inc.
Related search
Relative Hypocalcaemia and Muscle Cramps in Patients Receiving Imatinib for Gastrointestinal Stromal Tumour
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
Adjuvant Imatinib Mesylate After Resection of Localised, Primary Gastrointestinal Stromal Tumour: A Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet
Medicine
Gastrointestinal Stromal Tumors Treated With Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients
Radiology
Nuclear Medicine
Radiology
Imaging
Nationwide Trends in the Incidence and Outcome of Patients With Gastrointestinal Stromal Tumour in the Imatinib Era
British Journal of Surgery
Surgery
Phase II Trial of Continuous Regorafenib Dosing in Patients With Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib
Oncologist
Cancer Research
Medicine
Oncology
Comparison of Performance of Various Tumour Response Criteria in Assessment of Regorafenib Activity in Advanced Gastrointestinal Stromal Tumours After Failure of Imatinib and Sunitinib
European Journal of Cancer
Cancer Research
Oncology
Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated With Imatinib-Resistant Gastrointestinal Stromal Tumors
Clinical Cancer Research
Cancer Research
Oncology
Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis Following Treatment With Imatinib Mesylate
Cancer Research
Cancer Research
Oncology
